Renal Decline Slower With Rivaroxaban Than Warfarin in AF Patients Renal Decline Slower With Rivaroxaban Than Warfarin in AF Patients

The oral anticoagulant rivaroxaban is associated with both slower decline in kidney function and reduced risk of renal events compared with warfarin in atrial fibrillation patients.Medscape News UK
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news